COMMUNIQUÉS West-GlobeNewswire

Acasti Pharma Announces the Election of Its Directors, Changes to Its Stock Option Plan and Other Related Matters Approved at Its AGM
29/08/2018
MONTRÉAL, Aug. 29, 2018 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (NASDAQ:ACST) (TSX-V:ACST), a biopharmaceutical innovator focused on the research, development and commercialization of its prescription drug candidate [...]
Golden Leaf Reports Fiscal Second Quarter 2018 Results
29/08/2018
Reported Record Quarterly Revenue of US$3.7 million TORONTO, Aug. 29, 2018 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“Golden Leaf” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a cannabis company with cultivation, [...]
Krystal Biotech to Present at Upcoming B. Riley FBR and H.C. Wainwright Healthcare Investor Conferences
29/08/2018
PITTSBURGH, Aug. 29, 2018 (GLOBE NEWSWIRE) -- Krystal Biotech Inc. , (“Krystal”) (NASDAQ: KRYS), a gene therapy company dedicated to developing and commercializing novel treatments for patients suffering from skin [...]
TRACON Pharmaceuticals to Present at 2018 Wells Fargo Healthcare Conference
29/08/2018
SAN DIEGO, Aug. 29, 2018 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, [...]
Paratek Pharmaceuticals to Present at Baird's 2018 Global Healthcare Conference
29/08/2018
BOSTON, Aug. 29, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK) today announced that it will present at Baird's 2018 Global Healthcare Conference on Wednesday, September 5 at 10:15 a.m. EDT at the [...]
Aduro Biotech to Present at the 20th Annual H.C. Wainwright Global Investment Conference
29/08/2018
BERKELEY, Calif., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO) today announced that Stephen T. Isaacs, chairman, president and chief executive officer of Aduro, will present at the 20th Annual H. [...]
Allakos Announces Second Quarter 2018 Financial Results
29/08/2018
SAN CARLOS, Calif., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Allakos Inc. (NASDAQ:ALLK), a clinical stage biotechnology company focused on the development of antibodies for the treatment of eosinophil and mast cell related [...]
MyoKardia to Present at Two Upcoming Investor Conferences in September
29/08/2018
SOUTH SAN FRANCISCO, Calif., Aug. 29, 2018 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq:MYOK), a clinical-stage biopharmaceutical company pioneering precision medicine for the treatment of cardiovascular diseases, today [...]
Ascendis Pharma A/S Reports Second Quarter 2018 Financial Results
29/08/2018
- Continued advancement of endocrinology rare disease pipeline, paving way for application of TransCon ™ technology in a new therapeutic area - - Conference Call Today at 4:30 p.m. Eastern Time - COPENHAGEN, Denmark, [...]
OncoMed to Present at Two Upcoming Investor Conferences in September
29/08/2018
REDWOOD CITY, Calif., Aug. 29, 2018 (GLOBE NEWSWIRE) -- OncoMed Pharmaceuticals, Inc. (NASDAQ:OMED), a clinical-stage biopharmaceutical company focused on discovering and developing novel anti-cancer therapeutics, today [...]
Align Technology to Speak at an Upcoming Financial Conference
29/08/2018
SAN JOSE, Calif., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Align Technology, Inc. (Nasdaq: ALGN) today announced that the company is scheduled to speak at an upcoming financial conference. The presentation, as noted below, [...]
The Hydropothecary Corporation Changes Name to HEXO Corp. and Announces Voting Results from Special Meeting of Shareholders
29/08/2018
GATINEAU, Quebec, Aug. 29, 2018 (GLOBE NEWSWIRE) -- The Hydropothecary Corporation (“HEXO” or the “Company”) (TSX:HEXO) is pleased to announce that it has changed its corporate name from “The Hydropothecary Corporation [...]
Hydropothecary se dote d’un nouveau nom – HEXO Corp. – et annonce les résultats du scrutin tenu à son assemblée extraordinaire des actionnaires
29/08/2018
GATINEAU, Québec, 29 août 2018 (GLOBE NEWSWIRE) -- La société Hydropothecary (« HEXO » ou la « Société ») (TSX: HEXO) a le plaisir d’annoncer qu’elle a changé sa dénomination sociale, et qu’à partir d’aujourd’hui, elle [...]
NeuroMetrix to Exhibit and Sponsor Symposium on the Early Diagnosis of Diabetic Peripheral Neuropathy at the Annual Meeting of NEURODIAB
29/08/2018
WALTHAM, Mass., Aug. 29, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) today reported that it will be both exhibiting and sponsoring a diabetic neuropathy symposium at the 28th Annual Meeting of NEURODIAB [...]
New study on intensive rapid response system treatment in end-of-life care
29/08/2018
Study appears in September 2018 issue of The Joint Commission Journal on Quality and Patient Safety OAKBROOK TERRACE, Ill., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Many intensive interventions are delivered after rapid [...]
Assure Holdings Sets Second Quarter 2018 Conference Call for Thursday, August 30, 2018, at 11:00 a.m. ET
29/08/2018
DENVER, Aug. 29, 2018 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services, will hold a conference call on Thursday, [...]
OpGen to Present at the 20th Annual Rodman & Renshaw Global Investment Conference
29/08/2018
GAITHERSBURG, Md., Aug. 29, 2018 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ: OPGN) announced today that Evan Jones, Chairman and Chief Executive Officer, will present a corporate overview at the 20 th Annual Rodman & [...]
Trading in Coloplast shares by board members, executives or associated persons
29/08/2018
Nasdaq Copenhagen 29 August 2018 Report on transactions of executives and related parties in Coloplast shares and related securities According to the Market Abuse Regulation article 19 Coloplast is obliged to report on [...]
RAMSAY GENERALE DE SANTE : annual Results at the end of June 2018
29/08/2018
PRESS RELEASE Paris, 29 August 2018 Annual results at the end of June 2018 Resilient operating results in an unfavourable context Annual published turnover rose 0.3% to EUR 2,241.5 million (a 0.7% increase on a like-for [...]

Pages